In Vitro Activity of the New Glycopeptide LY333328 against Multiply Resistant Gram-Positive Clinical Isolates
- 1 September 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (9) , 2452-2455
Abstract
The in vitro activity of LY333328 was compared with those of vancomycin and teicoplanin against 425 gram-positive clinical isolates, including a variety of multiply resistant strains. LY333328 at ≤4 μg/ml inhibited all microorganisms tested, including methicillin- and teicoplanin-resistant staphylococci, glycopeptide-resistant enterococci, penicillin- and multiply resistant pneumococci, and viridans and beta-hemolytic streptococci.Keywords
This publication has 10 references indexed in Scilit:
- In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptideAntimicrobial Agents and Chemotherapy, 1997
- Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 1997
- Time-kill curves for a semisynthetic glycopeptide, LY333328, against vancomycin-susceptible and vancomycin-resistant Enterococcus faecium strainsAntimicrobial Agents and Chemotherapy, 1997
- In vitro activity and spectrum of LY333328, a novel glycopeptide derivativeAntimicrobial Agents and Chemotherapy, 1997
- Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococciAntimicrobial Agents and Chemotherapy, 1996
- In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococciAntimicrobial Agents and Chemotherapy, 1996
- Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococciAntimicrobial Agents and Chemotherapy, 1996
- Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.1993
- Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989The American Journal of Medicine, 1991
- Methicillin-resistant staphylococci: detection methods and treatment of infectionsAntimicrobial Agents and Chemotherapy, 1989